UF Health Cancer Center at 2023 ASCO Annual Meeting

The UF Health Cancer Center will be presenting at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting held June 2-6 in Chicago and virtually.

The ASCO Annual Meeting provides an unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care.

View the full program.

UF Health Cancer Center members appear in bold below.


Saturday, June 3 | 6:06-6:18 p.m.
Carcinogenic Origins of Early Onset of Colorectal Cancer
Christian Jobin

Panel Sessions

Friday, June 2 | 5:45-6:45 p.m.
Case-Based Panel S404
Navigating Retroperitoneal Sarcoma: Twists, Turns, and Challenges Ahead
Moderator: Julia Close

Saturday, June 3 | 2:15-3:15 p.m.
Case-Based Panel S102
Rare Gynecologic Cancers: A Case of Gestational Trophoblastic Neoplasia
Moderator: Martina Murphy

Plenary Session

Sunday, June 4 | 2:41 p.m.
PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048)
Deborah Schrag, Qian Shi, Martin Weiser, Marc Gollub, Leonard Saltz, Benjamin Musher, Joel Goldberg, Tareq Al Baghdadi, Karyn Goodman, Robert McWilliams, Jeffrey Farma, Thomas George, Hagen Kennecke, Alan Venook, Eileen O’Reilly, Jeffrey Meyerhardt, Amylou Dueck, Ethan Basch, George Chang, Harvey Mamon
Abstract #LBA2

Poster Discussion Sessions

Saturday, June 3 | 6:26-6:36 p.m
Final analysis of 2-THE-TOP: A phase 2 study of TTFields (Optune) plus pembrolizumab plus maintenance temozolomide (TMZ) in patients with newly diagnosed glioblastoma
David Tran, Ashley Ghiaseddin, Dongjiang Chen, Son Le
Abstract #2024

Sunday, June 4 | 12:30 p.m.
Hematology/oncology program director perspectives on recruitment and inclusion of a diverse workforce
Ana Velazquez Manana, Dame Idossa, Idalid Franco, Gerald Hsu, Martina Murphy, Evelin Trejo, Jenny Ruiz, Urshila Durani, Maria Garcia-Jimenez, Lachelle Weeks, Ariela Marshall, Narjust Florez, Vonetta Williams
Abstract #11005

Sunday, June 4 | 1:36-1:48 p.m.
Crafting Current Curricula: Bringing Oncology Education Into the Twenty-First Century
Julia Close

Sunday, June 4 | 6:26-6:36 p.m.
Axillary surgery efficacy for patients with breast cancer receiving neoadjuvant chemotherapy on NSABP B40 and B41
Raymond Mailhot Vega, Adeline Deladisma, Erin Mobley, Shu Wang, Christopher Morris, Oluwadamilola Oladeru, Eric Brooks, Bharatsinh Gharia, Lisa Spiguel, Shannon MacDonald, Eleftherios Mamounas, Nancy Mendenhall, Paul Okunieff, Ji-Hyun Lee, Leigh Neumayer, Julie Bradley
Abstract #524

Monday, June 5 | 6:04-6:16 p.m.
Physical and emotional quality of life in children with B-acute lymphoblastic leukemia randomized to every 4- vs. 12-week vincristine/dexamethasone during maintenance: Children’s Oncology Group AALL0932
Lyn Balsamo, John Kairalla, Emily Hibbitts, Rozalyn Rodwin, Meenakshi Devidas, Alexandra Dreyzin, Naomi Winick, William Carroll, Stephen Hunger, Elizabeth Raetz, Reuven Schore, Mignon Loh, Kirsten Ness, Anne Angiolillo, Nina Kadan-Lottick
Abstract #10025

Oral Abstracts

Sunday, June 4 | 10:45 a.m.–1:45 p.m.
A multicenter cooperative group study of late effects after high-risk neuroblastoma: COG ALTE15N2—LEAHRN study
Tara Henderson, Jenna Bardwell, Pei-Chi Kao, Paul Nathan, Wendy Landier, Sogol Mostoufi-Moab, Tara Brinkman, Julie Park, Saro Armenian, Arlene Naranjo, Meera Subramaniam, Araz Marachelian, Sharon Diskin, Wendy London, Lisa Diller
Abstract #10002

Monday, June 5 | 9:12-9:24 a.m.
Feasibility and acceptability of social determinants of health data collection in the context of a Children’s Oncology Group trial
Emily Jones, Arlene Naranjo, Lena Winestone, Puja Umaretiya, Rahela Aziz-Bose, Lenka Ilcisin, Emily Greengard, Steven DuBois, Rochelle Bagatell, Kira Bona
Abstract #10010

Poster Session

Saturday, June 3 | 9 a.m.-12 p.m.

Microbial metabolism of tryptophan is associated with resistance to immune checkpoint (ICB) therapy in renal cell cancer (RCC).
Shahla Bari, Humaira Sarfraz, Alicia Darwin, Jad Chahoud, Jameel Muzaffar, Mayer Fishman, Rohit Jain, Daniel George, Andrew Armstrong, Juskaran Chadha, John Powers, Tien Nguyen, Milton Wilches, Michael Jaglal, Melissa Sur, Michael Chrisopher, Robert Engelman, Timothy Garrett, Jose Conejo-Garcia, Brandon Manley
Abstract #4564

Saturday, June 3 | 2:15-5:15 p.m.

Evaluation of local control strategies on patterns of treatment failure in patients with localized Ewing sarcoma treated on AEWS1031: A report from the Children’s Oncology Group
Safia Ahmed, Odion Binitie, Mark Krailo, Allen Buxton, Daniel Indelicato, Alexandra Callan, Alexander Christ, Paul Chuba, Helen Nadel, Bruce Pawel, Richard Gorlick, Damon Reed, Steven DuBois, Katherine Janeway, Patrick Leavey, Leo Mascarenhas, Nadia Laack
Abstract #11529

A phase 2 study of an anti–PD-L1 antibody (atezolizumab) in dedifferentiated chondrosarcoma
Mohamad Salkeni, Brian Ko, Brian Van Tine, Anthony Conley, Elizabeth Davis, Melissa Burgess, Julia Close, Jared Foster, Geraldine O’Sullivan Coyne, Nancy Moore, Kristin Fino, Katherine Ferry-Galow, Christina Rosenberger, Ralph Parchment, Elad Sharon, James Doroshow, Alice Chen
Abstract #11533

Multimodal interventions targeting identified barriers to improve lung cancer screening in northeast Georgia
Swathi Kanakamedala, Shivang Danak*, Andria Caton
Abstract #6570

Sunday, June 4 | 9 a.m. – 12 p.m.

Empowering self-advocacy for breast health: A successful educational campaign on breast cancer risk and screening recommendations
Matthew Culbert, Eric Brooks, Teena Burchianti, Valerie Vázquez, Hope Boucher, Julie Bradley
Abstract #11041

Social determinants of health factors and palliative care services use among patients with metastatic breast cancer in Florida
Fantine Giap, Young-Rock Hong, Julie Bradley, Oluwadamilola Oladeru
Abstract #1102

Characterizing imposter syndrome among oncologists on social media
Eleonora Teplinsky, Sara Beltran Ponce, Don Dizon, Narjust Florez, Matthew Katz, Lindsey McAlarnen, Scott Moerdler, Martina Murphy, Hina Saeed, Maura Barry
Abstract #11018

Monday, June 5 | 9 a.m.-12 p.m.

A phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma: NEO-Nal-IRI study
Sherise C. Rogers, Ilyas Sahin, Jesus Fabregas, Ibrahim Nassour, Brian Ramnaraign, Kathryn Hitchcock, Steven Hughes, Ji-Hyun Lee, Omar Kayaleh, Anita Turk, Z. Fan, Karen Russell, David DeRemer, Carmen Allegra, Thomas George
Abstract #TPS4190

Alliance A022101: A pragmatic, randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
Kathryn Hitchcock, Paul Romesser, Qian Shi, Jesse Dixon, Sepideh Gholami, Sarah White, Christina Wu, Christopher Goulet, Kyung-Wook Jee, Chadwick Wright, Rona Yaeger, Ardaman Shergill, Theodore Hong, Thomas George, Eileen O’Reilly, Jeffrey Meyerhardt, Eric Miller
Abstract #TPS3629

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA)
Van Morris, Greg Yothers, Scott Kopetz, Shannon Puhalla, Peter Lucas, Atif Iqbal, Patrick Boland, Dustin Deming, Aaron Scott, Howard Lim, Theodore Hong, Norman Wolmark, Thomas George
Abstract #TPS3625

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008
Arvind Dasari, Guan Yu, Scott Kopetz, Samuel Jacobs, Peter Lucas, Ibrahim Sahin, Dustin Deming, Philip Philip, Theodore Hong, Yesenia Rojas-Khalil, Jonathan Loree, Norman Wolmark, Greg Yothers, Thomas George, Christopher Lieu
Abstract #TPS3634

Genomic landscapes of early-onset versus average-onset colorectal cancer populations
Michael Storandt, Qian Shi, Cathy Eng, Christopher Lieu, Melissa Stoppler, Thomas George, Elizabeth Mauer, Emily Teslow, Amit Mahipal, Zhaohui Jin
Abstract #3536

Alliance A022104/NRG-GI010: A randomized phase II trial testing the efficacy of triplet versus doublet chemotherapy to achieve clinical complete response in patients with locally advanced rectal cancer—The Janus Rectal Cancer trial
Jesse Joshua Smith, Arvind Dasari, Qian Shi, Julio Garcia-Aguilar, Hanna Sanoff, Thomas George, Theodore Hong, Greg Yothers, Philip Philip, Garth Nelson, Tareq Al Baghdadi, Olatunji Alese, Eileen O’Reilly, Jeffrey Meyerhardt, Ardaman Shergill, Natally Horvat, Paul Romesser, William Hall
Abstract #TPS3640

Monday, June 5 | 2:15-5:15 p.m.

Unveiling inequities in palliative care and clinical trial participation among patients with metastatic breast cancer in the state of Florida
Fantine Giap, Oluwadamilola Oladeru, Young-Rock Hong, Julie Bradley
Abstract #12120

Safety of checkpoint inhibitors in older patients with genitourinary cancers
Brian Ramnaraign, Neil Patel, Jonathan Chatzkel, Kathryn Hitchcock, Robert Zlotecki, Padraic O’Malley, Paul Crispen
Abstract #12059

Comprehensive Outcomes for After Cancer Health: COACH
Robin Lally, Rachael Schmidt, Gisele Tlusty, Mariah Jackson, Elizabeth Arthur, Austin Barr, Laura Flora, Marilyn Hammer, Jessica Jones, Debra Lynch Kelly, Jessica Krok-Schoen, Jennifer Loftis, Leorey Saligan, Angela Starkweather, Michael Vazquez, Meagan Whisenant, Alexi Wright, Kelly Brassil
Abstract #TPS12141

Patient-reported outcomes during pelvic radiation therapy: A secondary analysis on sexual function from NRG-RTOG 1203
Kelsey Corrigan, Rebecca Paulus, Ann Klopp, Lari Wenzel, Anamaria Yeung, J Thompson, Desiree Doncals, Vijayananda Kundapur, Nancy Wiggers, Dasarahally Mohan, Sharad Ghamande, Shannon Westin, Kara Schnarr, Michael Haas, David Gaffney, Steven Waggoner, Pamela Vanderwall, Noha Jastaniyah, Stephanie Pugh, Lisa Kachnic
Abstract #5533

Publication only

Exploring the benefits of therapeutic horticulture in patients in gynecologic oncology: A pilot study
Vasanti Jhaveri, Leah Diehl, Alexis Jennings-Coulibaly, Derek Li, Patricia Durning, Shazia Bashir, Merry Jennifer Markham, Alice Rhoton-Vlasak

Targeted inhibition of IRAK-4 with emavusertib on immune remodeling in metastatic brain melanoma
Christina Von Roemeling, Bently Doonan, Rylynn Russell, Tyler Elliott, Erica Matich, Vincent Archibald, Lan Hoang-Minh, Dora Ferrari, Jamison Hoffman, Duane Mitchell

Evaluating access to brentuximab in elderly patients with Hodgkin lymphoma
Erin Mobley, Yujia Li, Yi Guo, Dejana Braithwaite, John Wingard, Raymond Mailhot Vega

Improving multidisciplinary patient-centered care for adolescents and young adults with cancer
Leighton Elliott*, Joanne Lagmay, Daimian Scott, Lauren Staley

Acute myeloid leukemia (AML) outcomes in the era of novel therapies: A 9-year single-institution experience
Kriti Gera, Daniela Martir, Zhongyue Zhang, Carolyn Adams, Ashley Richards, Jack Hsu, John Hiemenz, Randy Brown, Erin Dean, Nosha Farhadfar, John Wingard, Zeina Al-Mansour

Incidence of hypomagnesemia in patients with HER2+ breast cancer treated with pertuzumab
Nirja Shah, Karen Daily

Does severity of periodontal disease influence the risk of developing gastrointestinal malignancies?
Umar Iqbal, Poliana Mendes Duarte, William Duncan, Zhanna Galochkina, Zhongyue Zhang, Stephen Kostewicz, Manuel Borobia, Ji-Hyun Lee, Sherise Rogers

Survival outcomes of acute erythroid leukemia in the United States: A 20-year population-based study
Kriti Gera, Daniela Martir, Wei Xue, John Wingard

Trends and characteristics of potentially preventable emergency department visits among patients with cancer in the US
Amir Alishahi Tabriz, Kea Turner, Young-Rock Hong, Benjamin Powers, Jennifer Lafata

Tele-oncology implementation logic model.
Amir Alishahi Tabriz, Kea Turner, Cristina Naso, Brian Gonzalez, Laura Oswald, Oliver Nguyen, Julie Hallanger-Johnson, Krupal Patel, Young-Rock Hong, Byron Powell, Philippe Spiess

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART SWOG 1609) in patients with refractory gallbladder cancer (cohort 48)
Sandip Patel, Elizabeth Guadarrama, Young Kwang Chae, Chih-Yi Liao, Anup Kasi, Grace Tarabay, Thomas George, Liam Chung, Gabby Lopez, Christine McLeod, Megan Othus, Helen Chen, Elad Sharon, Howard Streicher, Christopher Ryan, Charles Blanke, Razelle Kurzrock

Trends in utilization of first-line palliative care in non-metastatic hepatocellular carcinoma
Muhammet Ozer, Suleyman Goksu, Ilyas Sahin

Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in the United States (US): Final analysis of the prospective, observational REFINE study
Ahmed Kaseb, Roniel Cabrera, Renuka Iyer, Neehar Parikh, Richard Kalman, Kirhan Ozgurdal, Javeed Khan, Svetlana Babajanyan, Richard Finn

Impact of hospital volume and margin status on survival following radical hysterectomy: An expanded NCDB study
Vasanti Jhaveri*, Jean Tanner, Jason Salemi, Mitchell Kamrava, Thomas Rutherford, John David, Matthew Anderson

Standardization of pregnancy screening prior to chemotherapy: A quality improvement project
Nirja Shah*, Amy Laughlin, Terra Warner

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART SWOG 1609) in patients with refractory gallbladder cancer (cohort 48)
Sandip Patel, Elizabeth Guadarrama, Young Kwang Chae, Chih-Yi Liao, Anup Kasi, Grace Tarabay, Thomas George, Liam Chung, Gabby Lopez, Christine McLeod, Megan Othus, Helen Chen, Elad Sharon, Howard Streicher, Christopher Ryan, Charles Blanke, Razelle Kurzrock

*Indicates a UF student or trainee